Clinical Studies
Resonance Health is working with doctors at Sir Charles Gairdner Hospital (Associate Professor Leon Adams) and Fremantle Hospital (Professor John Olynyk) to recruit patients in Perth for the following study:
IIRON: Impact of iron and insulin resistance on liver histology in non-alcoholic steato-hepatitis.
The purpose of this study is to investigate the effects of reducing the amount of iron in the liver. This could improve liver damage due to non-alcoholic steato-hepatitis, commonly referred to as ‘NASH’. NASH is caused by an abnormal amount of fat in your liver, and is a serious form of chronic liver disease that includes inflammation and liver cell injury leading to fibrosis, cirrhosis (liver scarring), liver failure and ultimately, death. NASH is a ‘silent’ liver disease that affects 2-5% of the population worldwide. Because most individuals with NASH feel well and are not aware that they have a liver problem until there is progression to cirrhosis and its complications, developing new treatment options and interventions are of paramount importance.
You may be suitable to take part in this study if you:
· Are aged 18-65 years
· Are overweight or have diabetes
· Have had abnormal liver function blood tests
For more information about this study, please phone Helena Ching on (08) 9346 3983 or email helena.ching@health.wa.gov.au.
This study has been approved by the Sir Charles Gairdner Group Human Research Ethics Committee.
FerriScan Clinician Survey
As part of our on-going quality control and improvement program, Resonance Health is asking clinicians who have been using FerriScan to take part in a brief survey. This will help us to provide you with an even better service in 2011 and beyond.
The survey will take only a minute or two to complete and everyone taking part will be entered into a draw to win a hamper to the value of AUD $200.
Survey link
Please submit your completed survey by 31 January 2011.
Click here to take survey
|
Login
